Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001924908-26-000005

Options or other derivatives

  • Chief Legal Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Adler Reid G. Chief Legal Officer 2026-04-07 Grant or award · Incentive Stock Option (right to buy) +18,753 18,753 D
Adler Reid G. Chief Legal Officer 2026-04-07 Grant or award · Non-Qualified Stock Option (right to buy) +56,247 56,247 D
Loading xslF345X06/edgardoc.xml…